Stäng

SE - SV


Please select a country and, if applicable, a language.

Artikelöversikt

Acute cough: for the first time, a clear recommendation for ambroxol as symptomatic treatment


According to the guidelines of the German Respiratory Society, an acute cold cough without clinical indications of pneumonia or other warning signs, is the domain of self-medication. The duration – up ...

Till artikeln
Författare: Tobias Mück, PhDEFSM: 2021;1:210002DOI: 10.52778/efsm.21.0002Datum: 16.08.2021

Guideline recommendations for the treatment of abdominal pain (in irritable bowel syndrome)


Abdominal pain is common and impairs quality of life. Many specialist societies across the world have formulated guidelines on the treatment of irritable bowel syndrome and all of them mention antispa ...

Till artikeln
Författare: Thomas Weiser, PhDEFSM: 2021;1:210010DOI: 10.52778/efsm.21.0010Datum: 16.08.2021

Healthy adults with severe stress and hypomagnesaemia benefit from a combination of magnesium and …


This randomised, single-blind, clinical study investigated the effects of magnesium supplementation compared with combined administration of magnesium and vitamin B6. Whilst there were no significant ...

Till artikeln
Författare: Marion Eberlin, PhDEFSM: 2021;1:210011DOI: 10.52778/efsm.21.0011Datum: 16.08.2021

Treatment of acute pain: comparison of the efficacy of ibuprofen lysinate and ibuprofen


Relief that is rapid and effective is wanted when treating pain. A double-blind, placebo-controlled study investigated the efficacy, safety and tolerability of ibuprofen lysinate, ibuprofen acid and p ...

Till artikeln
Författare: Thomas Weiser, PhDEFSM: 2021;1:210012DOI: 10.52778/efsm.21.0012Datum: 16.08.2021

Recent meta-analysis on the efficacy of peppermint oil in irritable bowel syndrome


The meta-analysis demonstrated that peppermint oil is an effective and safe medicinal agent for treating the symptoms of irritable bowel syndrome. In seven clinical studies, peppermint oil was clearly ...

Till artikeln
Författare: Harald Weigmann, PhDEFSM: 2021;1:210013DOI: 10.52778/efsm.21.0013Datum: 16.08.2021

Caffeine – stimulating and aromatic: but safe!


The European Food Safety Authority has undertaken a comprehensive risk assessment and concluded that life-long regular consumption of caffeine of up to 400 mg daily from the age of 18 by healthy adult ...

Till artikeln
Författare: Thomas Weiser, PhDEFSM: 2021;1:210014DOI: 10.52778/efsm.21.0014Datum: 16.08.2021

Do caffeine-containing combination analgesics cause sleepless nights?


No relevant effects on the sleep quality of subjects were found in two studies in which ibuprofen combined with 100 mg caffeine was taken three times daily. Of a total of 538 patients, medication-indu ...

Till artikeln
Författare: Thomas Weiser, PhDEFSM: 2021;1:210015DOI: 10.52778/efsm.21.0015Datum: 16.08.2021

Analgesics with effect enhancers – combination analgesics with caffeine


A review by the Cochrane Collaboration compared the analgesic effects of a common analgesic with a combination of the analgesic and caffeine. The addition of caffeine significantly increased the propo ...

Till artikeln
Författare: Thomas Weiser, PhDEFSM: 2021;1:210016DOI: 10.52778/efsm.21.0016Datum: 16.08.2021

Fall asleep quickly – wake up refreshed!


Various causes, including stress and increased media consumption, lead to a reduction or even total absence of the release of endogenous melatonin, followed by problems falling asleep. According to th ...

Till artikeln
Författare: Tanja Schütt, PhDEFSM: 2021;1:210017DOI: 10.52778/efsm.21.0017Datum: 16.08.2021

From virus deactivation in-vitro to clinical relevance: a glycerol and cod trypsin-containing mouth…


Trypsin combined with glycerol caused the deactivation of common cold viruses in vitro. A pilot study and a comparative multicentre study investigated the in vivo reduction in viral load and the impro ...

Till artikeln
Författare: Tanja Schütt, PhD och Matthias Löhn, PhDEFSM: 2021;1:210018DOI: 10.52778/efsm.21.0018Datum: 16.08.2021